SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.337
NA - Nord America 9.076
AS - Asia 6.103
SA - Sud America 844
AF - Africa 178
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 6
Totale 34.596
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.131
US - Stati Uniti d'America 8.800
SG - Singapore 1.758
CN - Cina 1.643
GB - Regno Unito 1.332
HK - Hong Kong 652
BR - Brasile 627
VN - Vietnam 619
NL - Olanda 541
DE - Germania 394
SE - Svezia 364
FR - Francia 333
BD - Bangladesh 312
FI - Finlandia 270
KR - Corea 237
RU - Federazione Russa 209
TR - Turchia 186
UA - Ucraina 180
IN - India 145
CA - Canada 143
ID - Indonesia 127
AR - Argentina 84
CH - Svizzera 82
ES - Italia 80
JP - Giappone 79
MX - Messico 79
BG - Bulgaria 62
IE - Irlanda 60
PL - Polonia 57
IQ - Iraq 52
ZA - Sudafrica 50
AU - Australia 45
AT - Austria 43
PK - Pakistan 37
MA - Marocco 34
BE - Belgio 33
CO - Colombia 29
MY - Malesia 29
PH - Filippine 26
AE - Emirati Arabi Uniti 24
EG - Egitto 23
NO - Norvegia 23
TW - Taiwan 22
CL - Cile 21
CZ - Repubblica Ceca 21
IR - Iran 21
EC - Ecuador 20
VE - Venezuela 20
PE - Perù 19
SA - Arabia Saudita 19
RO - Romania 17
GR - Grecia 15
KE - Kenya 15
LT - Lituania 14
AL - Albania 13
MT - Malta 13
NP - Nepal 11
PY - Paraguay 11
DZ - Algeria 10
IL - Israele 10
KZ - Kazakistan 10
TH - Thailandia 10
UZ - Uzbekistan 10
BH - Bahrain 9
BO - Bolivia 9
PT - Portogallo 9
TN - Tunisia 9
AZ - Azerbaigian 7
BZ - Belize 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
NZ - Nuova Zelanda 7
HU - Ungheria 6
JO - Giordania 6
LV - Lettonia 6
OM - Oman 6
BY - Bielorussia 5
KG - Kirghizistan 5
MK - Macedonia 5
PA - Panama 5
SN - Senegal 5
HN - Honduras 4
NG - Nigeria 4
NI - Nicaragua 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CI - Costa d'Avorio 3
GE - Georgia 3
JM - Giamaica 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 34.544
Salva come PNG Salva come JPEG
Città #
Rome 1.243
Santa Clara 1.225
Milan 1.139
Singapore 1.112
Ashburn 907
Southend 872
Hefei 655
Hong Kong 640
San Jose 595
Naples 467
Fairfield 428
Chandler 408
Bologna 349
Florence 323
Turin 292
Woodbridge 258
Jacksonville 253
London 248
Houston 247
Council Bluffs 240
Seoul 224
Los Angeles 222
Beijing 215
Bari 209
Ho Chi Minh City 207
Nyköping 199
Dearborn 197
Helsinki 189
Ann Arbor 180
Wilmington 171
Chicago 167
Modena 163
New York 156
The Dalles 156
Seattle 153
Catania 147
Parma 147
Genoa 143
Hanoi 138
Palermo 138
Cambridge 111
Verona 109
Brescia 92
Izmir 92
Jakarta 92
Lauterbourg 89
Buffalo 85
São Paulo 84
Moscow 83
Padova 83
Cagliari 80
Pescara 74
Munich 71
Reggio Emilia 71
Shanghai 69
Dallas 67
Princeton 64
Orem 61
San Diego 61
Salt Lake City 60
Trieste 58
Livorno 57
Sofia 57
Tokyo 55
Vicenza 52
Trento 51
Rimini 49
Boardman 47
Frankfurt am Main 47
Eugene 44
Mexico City 43
Perugia 41
Toronto 41
Tampa 40
Ancona 35
Bremen 35
Des Moines 35
Elk Grove Village 35
Venice 35
Da Nang 34
Kent 34
Amsterdam 32
Dublin 32
Monza 32
Redwood City 32
Taranto 32
Ottawa 31
Paris 30
Treviso 30
Messina 29
Salerno 29
Bergamo 28
Falkenstein 28
Montreal 28
Ovada 28
Warsaw 28
Lucca 27
Stockholm 27
Valencia 27
Cesena 25
Totale 18.500
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.605
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.547
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.831
Farmaci biologici e infezione tubercolare 556
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 453
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 404
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 358
Biological Therapy and Risk of Malignancies: A Literature Review 358
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 347
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 346
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 337
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 332
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 315
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 314
Non HCV-related mixed cryoglobulinemia 309
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 303
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 302
Early Occupational Therapy Intervention: Patients’ Occupational Needs 292
HCV associated cryoglobulinemic vasculitis 275
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 269
EULAR guidelines on ANCA-associated vasculitis in the real life 269
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 267
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 266
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 263
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 258
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 255
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 251
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 248
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 248
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 246
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 245
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 245
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 243
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 242
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 242
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 240
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 238
Sanitary costs of osteoarthritis 236
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 236
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 230
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 228
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 223
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 222
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 220
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 220
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 216
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 215
On- and off-label use of rituximab in rheumatic diseases 212
Farmaci biologici ed epatiti da virus B e C 210
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 208
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 206
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 204
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 202
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 201
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 196
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 195
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 195
Endothelial Dysfunction in Acute Hepatic Porphyrias 195
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 193
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 193
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 187
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 185
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 184
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 181
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 179
Cryofibrinogen: A possibile risk factor in systemic sclerosis 177
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 177
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 176
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 173
Cryoproteinemia: new frontiers for clinicians and the laboratory 172
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 171
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 169
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 169
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 165
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 162
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 158
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 156
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 155
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 155
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 150
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 146
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 144
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 143
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 142
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 141
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 141
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 140
The management of large vessel vasculitides 140
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 138
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 134
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 132
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 129
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 125
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 124
Buerger's disease or thromboangiitis obliterans: description of two cases 121
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 115
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 113
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 107
The importance of body image and aesthetic medicine in systemic sclerosis 104
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 104
Totale 33.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 0 85
2021/20221.414 65 123 69 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/202611.259 832 616 1.051 1.492 1.377 693 1.256 594 958 951 894 545
Totale 34.791